Internal Medicine

 

Study Compares Fracture Risk Among Antidiabetes Medication Regimens

June 27, 2022

An analysis of real-world data from more than 6500 patients suggests insulin users had a greater risk of fracture than patients using metformin, but this became attenuated among patients using a combination of insulin and metformin.

Diabetes Dialogue: Prescribing Tirzepatide, Biosimilar Insulins, and Misdiagnosis of T1D

June 24, 2022

In this episode, Diana Isaacs, PharmD, and Natalie Bellini, DNP, discuss their experiences with prescribing tirzepatide (Mounjaro) and what issues patients have encountered, the prospect of new biosimilar insulins that may be coming to the market, and the misdiagnosis of type 1 diabetes in adult patients.

PCOS Increases Risk for Cardiovascular Complications During Delivery

June 22, 2022

Data from a Johns Hopkins Medicine-led analysis provide insight into the risk of cardiovascular complications among women with polycystic ovary syndrome during delivery hospitalizations compared to their counterparts without PCOS.

Annual Wellness Visits Linked to Lower Risk of Amputation in Type 2 Diabetes

June 21, 2022

An analysis of data from Medicare Fee-for-Service beneficiaries suggests patients attending annual wellness visits were 36% less likely to require lower limb amputation than their counterparts who did not attend an annual wellness visit that year.

In Pediatric T1D, Race, Income, & Insurance Type Remain Significant Barriers to Insulin Pump Use

June 14, 2022

An analysis of the SEARCH for Youth in Diabetes presented at ENDO 2022 details historic and contemporary disparities in insulin pump use for pediatric type 1 diabetes based on racial/ethnic background, household income, and insurance type.

Tirzepatide and Kidney Outcomes, with Hiddo Heerspink, PharmD, PhD

June 05, 2022

Hiddo Heerspink, PharmD, PhD, discusses a SURPASS-4 analysis examining kidney outcomes among patients receiving tirzepatide vs insulin glargine and provides perspective on the next steps for research as well as education.

Long COVID Could Be a Major Issue Looming Over Diabetes Community

June 04, 2022

New research from a review assessing risk of long COVID in patients with diabetes suggests the risk of developing long COVID in these patients could be more than 4-fold greater than the risk among patients without diabetes.